AMZN
Amazon.com, Inc.
AMZN has the edge over MPAA overall, supported by stronger fundamentals and stronger valuation.
MPAA
Motorcar Parts of America, Inc.
MPAA's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MPAA Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Under pressure |
MPAA's revenue, profitability, cash flow and balance sheet are all currently under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
MPAA PE Valuation
MPAA has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over MPAA on the outlook, with more favorable revenue expectations.
MPAA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect MPAA's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over MPAA on earnings quality, reporting a profit while its opponent remains loss making.
MPAA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.61 | — |
| Q3 2026 | -$0.16 | -233% |
| Q2 2026 | -$0.24 | -400% |
| Q1 2026 | $0.62 | +$1.61 |
| Q4 2025 | $0.10 | +$1.00 |
| Q3 2025 | $0.12 | +$3.53 |
| Q2 2025 | $0.08 | +$3.44 |
| Q1 2025 | -$0.99 | +$1.52 |
| Q4 2024 | -$0.90 | +$1.59 |
MPAA has swung to a loss: it lost $0.16 per share over the past year, after a profit the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over MPAA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over MPAA on profitability, with a higher operating margin.
MPAA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $169.2M | -24% |
| Q2 2026 | $168M | -11% |
| Q1 2026 | $212.3M | +9.9% |
| Q4 2025 | $167.7M | -9.9% |
| Q3 2025 | $221.5M | +6.4% |
| Q2 2025 | $188.4M | +11% |
| Q1 2025 | $193.1M | +1.9% |
| Q4 2024 | $186.2M | +8.3% |
MPAA's revenue has slid since its 2025 peak: $169M last quarter, down 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.9% | -1.5 points |
| Q2 2026 | 2.1% | -8.6 points |
| Q1 2026 | 9.9% | +1.5 points |
| Q4 2025 | 5% | -4.5 points |
| Q3 2025 | 7.4% | +1.4 points |
| Q2 2025 | 11% | +14 points |
| Q1 2025 | 8.4% | +2 points |
| Q4 2024 | 9.4% | +3.9 points |
MPAA's operating margin was 5.9% last quarter, down 1.5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
MPAA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.8M | -123% |
| Q2 2026 | -$12.4M | -235% |
| Q1 2026 | -$6M | -195% |
| Q4 2025 | -$8.6M | -126% |
| Q3 2025 | $20.8M | -6.5% |
| Q2 2025 | $9.2M | +$30.6M |
| Q1 2025 | $6.2M | +$16.1M |
| Q4 2024 | $33.7M | -37% |
MPAA has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over MPAA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
MPAA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +19% | +3.6M shares |
| 1 year | +16% | +3.1M shares |
| 3 years | +15% | +2.9M shares |
| 5 years | +15% | +2.9M shares |
| Available history | +16% | +3.2M shares |
MPAA has 22M diluted shares, up 16% from a year ago, despite $10M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1.9M |
| Q1 2026 | $3M |
| Q4 2025 | $5M |
| Q3 2025 | $1.4M |
| Q2 2025 | $2M |
| Q1 2025 | $2.7M |
| Q1 2023 | — |
MPAA spent $10M buying back its own shares over the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MPAA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | 3.0x | Elevated |
| Q2 2024 | 3.5x | Elevated |
| Q1 2024 | 2.0x | Moderate |
| Q4 2023 | 1.5x | Healthy |
| Q3 2023 | 2.5x | Moderate |
| Q2 2023 | 3.1x | Elevated |
| Q1 2023 | 2.8x | Moderate |
| Q1 2020 | 3.9x | Elevated |
MPAA's net debt is about 3.0 years of its operating earnings (EBITDA), up from 2.5 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
MPAA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.6 | Oversold |
| Stochastic | 11.6 | Oversold |
MPAA's weekly RSI is 27 (oversold) and its Stochastic is 12 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
MPAA PE vs Consumer Cyclical Sector
| Metric | MPAA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
MPAA has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over MPAA on trend strength, trading above more of its moving averages.
MPAA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.1 | 24% below |
| 20 week MA | $11.7 | 34% below |
| 50 week MA | $11.9 | 35% below |
| 100 week MA | $11.6 | 34% below |
| 200 week MA | $9.65 | 20% below |
MPAA is in a downtrend: it's below all five of its weekly moving averages, and 20% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over MPAA on returns for 2026, with the stronger performance.
MPAA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.9 | $19.9 | -9.2% |
| 2021 | $19.9 | $16.7 | -16% |
| 2022 | $16.7 | $11.3 | -32% |
| 2023 | $11.3 | $9.34 | -17% |
| 2024 | $9.34 | $8.05 | -14% |
| 2025 | $8.05 | $12.5 | +55% |
| 2026 YTD | $12.5 | $7.71 | -38% |
MPAA has finished lower in five of the last six years. It's down 38% so far in 2026.